Our options are readily available
What are you doing to create that circle of trust around you
Zepbound (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that is FDA-approved along with increased physical activity and a reduced-calorie diet for chronic weight management in adults with a starting body mass index (BMI) of: 30 kg/m^2 or higher (obesity) or 27 kg/m^2 or higher (overweight) with at least one weight-related condition such as high cholesterol, high blood pressure (hypertension), type 2 diabetes, heart disease, or obstructive sleep apnea
Symptoms include trembling, sweating, confusion, rapid heartbeat, and dizziness
The GIP activation appears to buffer gastrointestinal distress rather than compound it, which bodes well for real-world adherence
If you are still feeling unsure about where to begin, we invite you to take our Cymbiotika Expert for a personalized recommendation tailored to your specific needs